Table 1:
Number | 20 |
---|---|
Age, Median | 56.5 (37–67) |
Sex | |
Male | 10 |
Female | 10 |
Race | |
Caucasion | 20 |
Ethnicity | |
Non-Hispanic | 19 |
Hispanic | 1 |
ECOG | |
0 | 10 |
1 | 10 |
Viral hepatitis | 0 |
Liver cirrohsis | 0 |
M1 disease | |
Yes | 16 |
No | 4 |
Primary disease | |
Extrahepatic | 6 |
Intrahepatic | 12 |
Gallbladder | 2 |
Prior stent placement | 4 |
New stent placement during trial | 1 |
Previous therapy | |
Any Surgical resection | 7 |
Any TACE | 1 |
Any Chemotherapy | 20 |
Any Radiation therapy | 2 |
Reason for discontinuation | |
PD | 17 |
Toxicity | 3 |
CA19.9 | |
>200 U/mL | 8 |
<200 U/mL | 12 |